- E27.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E27.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E27.3 – other international versions of ICD-10 E27.3 may differ.
ICD-10-CM E27.3 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E27.3:
- drug-induced > adrenocortical E27.40
- drug-induced > adrenocortical E27.40
- iatrogenic > adrenocortical E27.40
- insufficiency > effects (adverse) (adrenocortical) (iatrogenic) E24.2